2026

The Battle Over Mifepristone Access in 2026

Mifepristone, commonly known as Mife, is a safe and effective medication approved by the U.S. Food and Drug Administration (FDA) more than 25 years ago. It has been used by millions of patients in the...

Virginia Has the Opportunity to Lead on Lowering Prescription Drug Costs

The high cost of prescription drugs continues to strain families and state budgets alike. Now, Virginia has the opportunity to take a major step forward in lowering drug costs for families at the stat...

Families USA Submits Testimony in Support of LD 2196 to Lower Health Insurance Costs and Reduce Barriers to Care

On March 5, 2026, Sophia Tripoli, Senior Director of Health Policy at Families USA, submitted written testimony to the Maine Joint Standing Committee on Health and Human Services, in support of LD 21...

Higher Deductibles, More Barriers, Fewer Protections: How the New Marketplace Rule Would Further Erode Access to Affordable, Quality Health Coverage

People who buy coverage individually through the marketplace will be negatively impacted by new regulations proposed by the Trump Administration, which would promote plans with higher deductibles and ...

Families USA Submits Comment Letter on Proposed Transparency in Coverage (TiC) Rule

Families USA, on behalf of the Consumers First steering committee, submitted comments on the Centers for Medicare & Medicaid Services (CMS) proposed Transparency in Coverage (TiC) rule. Consumers...

Families USA Comment on GUARD Drug Pricing Model

Families USA submitted comment on the Centers for Medicare & Medicaid Services (CMS) model GUARD (Guarding U.S. Medicare Against Rising Drug Costs). Families USA supports the broader efforts to...

Families USA Submits Comment Letter on Proposed Rule Blocking Access to Gender-Affirming Care

Families USA submitted comments on the Centers for Medicare & Medicaid Services (CMS) proposed rule Medicare and Medicaid Programs; Hospital Conditions of Participation: Limiting Participation Bas...

The Trump Administration’s Latest Attack on Medically Necessary, Gender-Affirming Care

The Trump Administration’s Latest Attack on Medically Necessary, Gender- Affirming Care The Trump administration is continuing its attacks on access to health care for transgender Americans, ...

Families USA Submits Testimony Expressing Support for the Fair Pricing Act

On February 10th, 2026, Families USA submitted written testimony to the New York State Joint Legislative Budget Hearing on Health, expressing support for the Fair Pricing Act (S. 705/A. 2140). ...

Our Courts Are Deciding the Future of Childhood Vaccines: What Advocates Need to Know

President Trump and HHS Secretary Kennedy are reshaping America’s public health infrastructure by taking unprecedented steps to alter the childhood vaccine schedule — changes driven by ideology ra...